SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - TLISPRNewsWire • 01/27/22
TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Talis Biomedical Corporation (NASDAQ: TLIS)PRNewsWire • 01/26/22
TLIS DEADLINE: Talis Biomedical Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNewsfile Corp • 01/26/22
Kessler Topaz Meltzer & Checker, LLP: March 8, 2022 Deadline Reminder for Talis Biomedical Corporation Investors in Securities Fraud Class Action LawsuitPRNewsWire • 01/24/22
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Before March 8, 2022Business Wire • 01/21/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLISPRNewsWire • 01/20/22
TLIS ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - TLISPRNewsWire • 01/20/22
TLIS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Was Filed Against Talis Biomedical CorporationNewsfile Corp • 01/19/22
Shareholder Alert: Robbins LLP Reminds Investors that Talis Biomedical Corporation (TLIS) is Being Sued for Misleading ShareholdersBusiness Wire • 01/18/22
TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Talis Biomedical Corporation Shareholders of Class Action and Lead Deadline: March 8, 2022Business Wire • 01/17/22
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Talis Biomedical Corporation and Encourages Investors with Substantial Losses to Contact the FirmBusiness Wire • 01/16/22
TLIS ALERT: Talis Biomedical Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 01/15/22
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical CorporationPRNewsWire • 01/15/22
Rosen, Leading Investor Counsel, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TLISNewsfile Corp • 01/14/22
Rosen, A Top Ranked Law Firm, Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TLISNewsfile Corp • 01/13/22
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)Business Wire • 01/13/22
Shareholder Alert: Robbins LLP Informs Investors that Talis Biomedical Corporation (TLIS) is Being Sued for Misleading ShareholdersBusiness Wire • 01/12/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the FirmBusiness Wire • 01/12/22
TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors to Contact Firm's Attorneys, IPO-Related Securities Class Action FiledPRNewsWire • 01/12/22
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLISBusiness Wire • 01/11/22
DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLISPRNewsWire • 01/11/22
TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation (NASDAQ: TLIS)PRNewsWire • 01/11/22
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)Business Wire • 01/11/22
ALERT: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLISBusiness Wire • 01/10/22
TLIS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Talis Biomedical CorporationBusiness Wire • 01/10/22
